Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Castillo-Trivino

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|July 12, 2013
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic reviewTamara Castillo-Trivino, Dejana Braithwaite, Peter Bacchetti, et al.
Clinical Neuropharmacology|March 19, 2013
Clinical response to thalidomide in the treatment of intracranial tuberculomas: case reportPatricia de la Riva, Miguel Urtasun, Tamara Castillo-Trivino, et al.
Frontiers in Microbiology|April 10, 2025
A proposed workflow to robustly analyze bacterial transcripts in RNAseq data from extracellular vesiclesAlex M Ascensión, Miriam Gorostidi-Aicua, Ane Otaegui-Chivite, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Plos One|February 10, 2011
Switching multiple sclerosis patients with breakthrough disease to second-line therapyTamara Castillo-Trivino, Ellen M Mowry, Alberto Gajofatto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2024
Association of Complement Factors With Disability Progression in Primary Progressive Multiple SclerosisJan D Lunemann, Harald Hegen, Luisa María Villar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2022
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data networkAlessio Signori, Johannes Lorscheider, Sandra Vukusic, et al.
Neurology|April 21, 2021
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple SclerosisWei Zhen Yeh, Putu Ayu Widyastuti, Anneke Van der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2023
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trialIbrahima Diouf, Charles B Malpas, Sifat Sharmin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|July 12, 2013
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic reviewTamara Castillo-Trivino, Dejana Braithwaite, Peter Bacchetti, et al.
Clinical Neuropharmacology|March 19, 2013
Clinical response to thalidomide in the treatment of intracranial tuberculomas: case reportPatricia de la Riva, Miguel Urtasun, Tamara Castillo-Trivino, et al.
Frontiers in Microbiology|April 10, 2025
A proposed workflow to robustly analyze bacterial transcripts in RNAseq data from extracellular vesiclesAlex M Ascensión, Miriam Gorostidi-Aicua, Ane Otaegui-Chivite, et al.
Plos One|April 7, 2021
O group is a protective factor for COVID19 in Basque populationMaider Muñoz-Culla, Andres Roncancio-Clavijo, Bruno Martínez, et al.
Plos One|February 10, 2011
Switching multiple sclerosis patients with breakthrough disease to second-line therapyTamara Castillo-Trivino, Ellen M Mowry, Alberto Gajofatto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2024
Association of Complement Factors With Disability Progression in Primary Progressive Multiple SclerosisJan D Lunemann, Harald Hegen, Luisa María Villar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2022
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data networkAlessio Signori, Johannes Lorscheider, Sandra Vukusic, et al.
Neurology|April 21, 2021
Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple SclerosisWei Zhen Yeh, Putu Ayu Widyastuti, Anneke Van der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2023
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trialIbrahima Diouf, Charles B Malpas, Sifat Sharmin, et al.
Pageof 2